WISE Secures $30 Million in Latest Series D Funding Round

WISE secured $30 million in its latest Series D, adding another data point to the Healthcare & Life Sciences funding market.

WISE Raises $30 million in Funding

WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

WISE operates in Healthcare & Life Sciences. WISE's Series D round shows investors are still backing digital health platforms with real scale narratives. At $30M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Support neurostim tech - MassDevice.

Looking Ahead

WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor

Source reference: original announcement/article.